Improving Definitive Therapy Among Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections: Predictors of Early Therapeutic Switch to Linezolid or Daptomycin

BACKGROUND: Vancomycin is a first-line antibiotic for treating methicillin-resistant S. Aureus bloodstream infections (MRSA BSI), due to its activity against MRSA and low cost. If vancomycin fails, patients are often switched to daptomycin or linezolid. We aimed to determine predictors for switching...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Forum Infect Dis
Asıl Yazarlar: Schweizer, Marin, Richardson, Kelly, Sarrazin, Mary Vaughan, Jones, Michael, Livorsi, Daniel, Nair, Rajeshwari, Goto, Michihiko, Alexander, Bruce, Beck, Brice, Perencevich, Eli
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631808/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.654
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller